Doctor reminders to increase aspirin use for preeclampsia prevention
Part of Women’s health & pregnancy clinical trials.
This study tests whether alerting doctors helps more pregnant people with increased risk for preeclampsia start taking low-dose aspirin to prevent it. If you're at higher risk, taking aspirin might help protect you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are pregnant and between 12 and 28 weeks along.
- Your doctor has identified you as having an increased risk for preeclampsia (a pregnancy complication involving high blood pressure).
- You are receiving your prenatal care at a participating clinic or hospital.
- You do not have any medical condition that makes aspirin unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether taking aspirin for a longer or shorter time during pregnancy can better prevent preeclampsia, a serious condition with high blood pressure. It is for pregnant women already taking daily aspirin and found to be at high risk.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.
This study compares two doses of aspirin (150 mg vs 100 mg) to see which is better at preventing preeclampsia, a serious pregnancy complication involving high blood pressure, in women who are obese and at higher risk. If you qualify, you would take one aspirin dose daily during pregnancy.
This study looks for blood markers that may predict whether low-dose aspirin will “work” to prevent preeclampsia in a next pregnancy. It may help improve which patients benefit most from aspirin and guide safer prevention in future pregnancies.
This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.